Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 15,642 |
|
|||||
| News | - | ||||||
| Day High | 14.1206 | Low High |
|||||
| Day Low | 13.405 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cidara Therapeutics Inc | CDTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.305 | 2.24% | 13.915 | 12:02:37 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 13.73 | 13.405 | 14.1206 | 13.61 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 279 | 15,642 | $ 13.69 | $ 214,084 | - | 10.004 - 29.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:00:49 | 3 | $ 13.91 | USD |
Cidara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.26B | 90.43M | - | 63.91M | -22.93M | -0.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cidara Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.20 | 14.1206 | 11.0161 | 12.53 | 80,793 | 1.72 | 14.06% |
| 1 Month | 21.40 | 22.00 | 10.004 | 13.34 | 686,319 | -7.49 | -34.98% |
| 3 Months | 14.30 | 24.40 | 10.004 | 15.95 | 712,129 | -0.385 | -2.69% |
| 6 Months | 16.378 | 24.40 | 10.004 | 15.55 | 679,006 | -2.46 | -15.04% |
| 1 Year | 20.80 | 29.60 | 10.004 | 18.79 | 671,970 | -6.89 | -33.10% |
| 3 Years | 41.00 | 47.80 | 8.00 | 24.49 | 819,558 | -27.09 | -66.06% |
| 5 Years | 48.00 | 89.00 | 8.00 | 31.45 | 648,693 | -34.09 | -71.01% |
Cidara Therapeutics Description
| Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. |
